A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
People should only be allowed to move freely within the EU if they have a job waiting for them, the Home Secretary has said.
A 62-year-old woman has been found alive more than a week after she vanished while on a hiking trip.
The first African American actor to play the lead role in Les Misérables on Broadway has died, aged 21.